Press Releases

01.05.2015

Pfizer Acquires Redvax GmbH

12.24.2014

Kissei Announces Licensing Agreement with Pfizer Inc. for KUX-1151, a Novel Investigational Therapy for Gout and Hyperuricemia

12.22.2014

PHILOGEN ANNOUNCES OPTION AND LICENSE AGREEMENT WITH PFIZER INC. TO DEVELOP AND COMMERCIALIZE MULTIPLE ANTIBODY DRUG CONJUGATES AND TARGETED NANOPARTICLES

12.08.2014

iTeos Therapeutics Announces License and Collaboration with Pfizer Inc. for Discovery and Development of Cancer Immunosuppression Targets

12.08.2014

Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc.

12.03.2014

WADA Signs a Global Collaboration Agreement with Pfizer Inc.

12.02.2014

Lpath Completes Enrollment in its Phase 2 Clinical Trial of iSONEP for Wet Age-Related Macular Degeneration

11.18.2014

Sanguine’s Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research

09.25.2014

Pfizer Completes Acquisition Of InnoPharma

09.22.2014

Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations

09.16.2014

MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for Parkinson’s Disease

08.26.2014

Pfizer And Merck To Collaborate On Study Evaluating Novel AntiCancer Combination Regim